Ironwood Pharmaceuticals | IRWD - Net Income


Ironwood Pharmaceuticals reported $3.19M in Net Income for its fiscal quarter ending in December of 2024.





Net Income Change Date
Acadia Pharmaceuticals USD 273.57M 201.79M Dec/2025
Agios Pharmaceuticals USD -108.04M 4.61M Dec/2025
Akebia Therapeutics USD -12.24M 12.78M Dec/2025
Almirall EUR 19.58M 7M Dec/2025
Alnylam Pharmaceuticals USD 186.42M 64.66M Dec/2025
Amarin USD -1.22M 6.51M Dec/2025
Ardelyx USD -407K 562K Dec/2025
Astellas Pharma JPY 100.38B 21.17B Dec/2025
AstraZeneca USD 2.33B 207M Dec/2025
Charles River Laboratories USD -276.56M 330.98M Dec/2025
Coherus Biosciences USD -37.64M 2.11M Dec/2025
Emergent BioSolutions USD -261.3M 78.3M Jun/2023
Esperion Therapeutics USD 61.83M 93.16M Dec/2025
Halozyme Therapeutics USD -141.59M 316.82M Dec/2025
Incyte USD 299.28M 124.89M Dec/2025
Ironwood Pharmaceuticals USD 3.19M 457K Dec/2024
Karyopharm Therapeutics USD -102.2M 71.42M Dec/2025
Lexicon Pharmaceuticals USD -15.53M 2.76M Dec/2025
MacroGenics USD -14.16M 30.98M Dec/2025
Moderna USD -200M 625M Sep/2025
Myriad Genetics USD -7.9M 19.5M Dec/2025
Pacira USD 1.64M 3.8M Dec/2025
PTC Therapeutics USD -134.96M 150.86M Dec/2025
Puma Biotechnology USD 20.32M 24.85M Sep/2024
Sarepta Therapeutics USD -412.23M 232.28M Dec/2025
Takeda JPY 103.64B 115.44B Dec/2025
Ultragenyx Pharmaceutical USD -129M 51.41M Dec/2025
Vanda Pharmaceuticals USD -18.9M 13.58M Dec/2024